A University of Alberta professor is co-leading a new international vaccine safety network to examine why some people who received a COVID-19 vaccine experienced very rare adverse events associated with the vaccine.
Observed cases of Guillain-Barré syndrome after receipt of the Janssen shot were two to three times greater than background rates within 3-6 weeks of vaccination, new US surveillance data show.